These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 34874466)

  • 21. Solution behaviour and biomolecular interactions of two cytotoxic trans-platinum(II) complexes bearing aliphatic amine ligands.
    Cubo L; Casini A; Gabbiani C; Mastrobuoni G; Messori L; Jiménez-Barbero J; Navarro-Ranninger C; Quiroga AG
    Chemistry; 2009 Sep; 15(36):9139-46. PubMed ID: 19655350
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Trans-diammineplatinum(II): what makes it different from cis-DDP? Coordination chemistry of a neglected relative of cisplatin and its interaction with nucleic acids.
    Lippert B
    Met Ions Biol Syst; 1996; 33():105-41. PubMed ID: 8742842
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 2D-QSAR study, molecular docking, and molecular dynamics simulation studies of interaction mechanism between inhibitors and transforming growth factor-beta receptor I (ALK5).
    Jiang MN; Zhou XP; Sun DR; Gao H; Zheng QC; Zhang HX; Liang D
    J Biomol Struct Dyn; 2018 Nov; 36(14):3705-3717. PubMed ID: 29064324
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Carbon nanohorns as nanocontainers for cisplatin: insight into their interaction with the plasma membranes of normal and breast cancer cells.
    Almeida ER; Dos Santos HF; Capriles PVSZ
    Phys Chem Chem Phys; 2021 Aug; 23(30):16376-16389. PubMed ID: 34318822
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis, Antiproliferative and Cytotoxic Activities, DNA Binding Features and Molecular Docking Study of Novel Enamine Derivatives.
    Burcu Gürdere M; Aydin A; Yencilek B; Ertürk F; Özbek O; Erkan S; Budak Y; Ceylan M
    Chem Biodivers; 2020 Jul; 17(7):e2000139. PubMed ID: 32374947
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of cisplatin-binding proteins using agarose conjugates of platinum compounds.
    Karasawa T; Sibrian-Vazquez M; Strongin RM; Steyger PS
    PLoS One; 2013; 8(6):e66220. PubMed ID: 23755301
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of the amine non-leaving group on the structure and stability of DNA complexes with cis-[Pt(R-NH2)2(NO3)2].
    Butour JL; Alvinerie P; Souchard JP; Colson P; Houssier C; Johnson NP
    Eur J Biochem; 1991 Dec; 202(3):975-80. PubMed ID: 1765105
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Temporal behavior of DNA thermal stability in the presence of platinum compounds. Role of monofunctional and bifunctional adducts.
    Lando DY; Galyuk EN; Chang CL; Hu CK
    J Inorg Biochem; 2012 Dec; 117():164-70. PubMed ID: 23085597
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Metal complexes with aromatic N-containing ligands as potential agents in cancer treatment.
    Zhao G; Lin H
    Curr Med Chem Anticancer Agents; 2005 Mar; 5(2):137-47. PubMed ID: 15777221
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Binding mode analysis, dynamic simulation and binding free energy calculations of the MurF ligase from Acinetobacter baumannii.
    Ahmad S; Raza S; Uddin R; Azam SS
    J Mol Graph Model; 2017 Oct; 77():72-85. PubMed ID: 28843462
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Unusual reactivity of cytotoxic cis-dihydrazide Pt(II) complexes in aqueous solution.
    Kushev D; Grünert R; Spassovska N; Golovinsky E; Bednarski PJ
    J Inorg Biochem; 2003 Sep; 96(4):469-77. PubMed ID: 13678813
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cooperative hydrogen bonds and mobility of the non-aromatic ring as selectivity determinants for human acetylcholinesterase to similar anti-Alzheimer's galantaminics: a computational study.
    Rocha REO; Lima LHF
    J Biomol Struct Dyn; 2019 Apr; 37(7):1843-1856. PubMed ID: 29697300
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Computational metallomics of the anticancer drug cisplatin.
    Calandrini V; Rossetti G; Arnesano F; Natile G; Carloni P
    J Inorg Biochem; 2015 Dec; 153():231-238. PubMed ID: 26490711
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Binding energies and hydrogen bonds effects on DNA-cisplatin interactions: a DFT-xTB study.
    Ludwig V; da Costa Ludwig ZM; Modesto MA; Rocha AA
    J Mol Model; 2024 May; 30(6):187. PubMed ID: 38801468
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Elucidation of the molecular interaction between cisplatin and flavonol(s) and their effect on DNA binding.
    Zwang TJ; Singh K; Johal MS; Selassie CR
    J Med Chem; 2013 Feb; 56(4):1491-8. PubMed ID: 23360392
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Elasticity of cisplatin-bound DNA reveals the degree of cisplatin binding.
    Lee NK; Park JS; Johner A; Obukhov S; Hyon JY; Lee KJ; Hong SC
    Phys Rev Lett; 2008 Dec; 101(24):248101. PubMed ID: 19113672
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Structural characterization, DNA interactions, and cytotoxicity of new transplatin analogues containing one aliphatic and one planar heterocyclic amine ligand.
    Ramos-Lima FJ; Vrána O; Quiroga AG; Navarro-Ranninger C; Halámiková A; Rybnícková H; Hejmalová L; Brabec V
    J Med Chem; 2006 Apr; 49(8):2640-51. PubMed ID: 16610807
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antitumor effects of a tetradentate amido-carboxylate ligands and corresponding square-planar palladium(II) complexes toward some cancer cells. Crystal structure, DFT modeling and ligand to DNA probe docking simulation.
    Matović ZD; Mrkalić E; Bogdanović G; Kojić V; Meetsma A; Jelić R
    J Inorg Biochem; 2013 Apr; 121():134-44. PubMed ID: 23376555
    [TBL] [Abstract][Full Text] [Related]  

  • 39. cis-[PtCl2(4,7-H-5-methyl-7-oxo[1,2,4]triazolo[1,5-a]pyrimidine)2]: a sterically restrictive new cisplatin analogue. Reaction kinetics with model nucleobases, DNA interaction studies, antitumor activity, and structure-activity relationships.
    Navarro JA; Salas JM; Romero MA; Vilaplana R; Gonzalez-Vílchez F; Faure R
    J Med Chem; 1998 Jan; 41(3):332-8. PubMed ID: 9464364
    [TBL] [Abstract][Full Text] [Related]  

  • 40. New chalcone-tethered 1,3,5-triazines potentiate the anticancer effect of cisplatin against human lung adenocarcinoma A549 cells by enhancing DNA damage and cell apoptosis.
    El-Wakil MH; Khattab SN; El-Yazbi AF; El-Nikhely N; Soffar A; Khalil HH
    Bioorg Chem; 2020 Dec; 105():104393. PubMed ID: 33120322
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.